Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Hypertension. 2019 May 13;74(1):83–94. doi: 10.1161/HYPERTENSIONAHA.119.12873

Figure 2. Mouse renin concentrations in non-diabetic and diabetic mice, 8 (A) and 20 weeks after the last STZ injection (B).

Figure 2.

Panel A: higher mouse renin/Cr ratio in urines from diabetic FVB mice (STZ, black, n=15) compared to non-diabetic FVB mice (Veh, white, n=9) 8 weeks after the last injection of steptozotocin. Panel B: higher mouse renin/Cr ratio in urines of diabetic FVB mice (STZ, black, n=15) compared to non-diabetic FVB mice (Veh, white, n=8) 20 weeks after the last injection of streptozotocin. Data shown as mean ± SE. Veh: control mice treated with vehicle; STZ: Streptozotocin-treated mice; **p<0.01, ***p<0.001